SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-032116
Filing Date
2024-02-12
Accepted
2024-02-12 16:26:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d749523dsc13ga.htm SC 13G/A 43692
  Complete submission text file 0001193125-24-032116.txt   45145
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Subject) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91717 | Film No.: 24620377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRELUDE THERAPEUTICS INCORPORATED 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address
Vaddi Krishna (Filed by) CIK: 0001824633 (see all company filings)

Type: SC 13G/A